SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-042615
Filing Date
2021-08-09
Accepted
2021-08-09 16:05:39
Documents
14
Period of Report
2021-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K allk-8k_20210809.htm   iXBRL 8-K 44532
2 EX-99.1 allk-ex991_6.htm EX-99.1 226051
3 GRAPHIC gddkmgmmj12d000001.jpg GRAPHIC 16725
  Complete submission text file 0001564590-21-042615.txt   433443

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA allk-20210809.xsd EX-101.SCH 5681
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE allk-20210809_lab.xml EX-101.LAB 19352
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE allk-20210809_pre.xml EX-101.PRE 11485
7 EXTRACTED XBRL INSTANCE DOCUMENT allk-8k_20210809_htm.xml XML 3530
Mailing Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065
Business Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 211156447
SIC: 2834 Pharmaceutical Preparations